Pioneering Next Generation
Exploiting DDR vulnerabilities and harnessing the power of the immune response in oncology
Committed to Innovation
We have an unwavering commitment to delivering novel, life-saving cancer treatments to improve patient outcomes.
Exploiting DDR vulnerability
We utilise a precision medicine approach to effectively target specific genetic alterations in cancer.
Harnessing immune system
We harness the power of the immune system’s complex network of cells and proteins to activate the anti-tumour immune response.